Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-033113.htm |
| EX-32.1 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex3201.htm |
| EX-31.1 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex3101.htm |
| EX-31.2 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex3102.htm |
| EX-32.2 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex3202.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Brooklyn ImmunoTherapeutics, Inc. | Financial_Report.xls |
Exhibit 10.1
SECOND AMENDMENT TO
CONSULTING AGREEMENT
DATED AS OF JULY 2, 2012 BETWEEN
NTN BUZZTIME, INC. AND JABAM, INC.
The following amendment to the above-referenced Agreement between NTN BUZZTIME, INC. and JABAM INC. are made and effective as of March 20, 2013.
| A. | Section 2.1 is amended to read, in its entirety, as follows: |
The term of this Agreement shall commence on July 2, 2012 (the "Effective Date") and, unless earlier terminated in accordance with Section 7 shall expire on June 30, 2013.
| NTN BUZZTIME, INC. | JABAM, INC. |
| By: /s/ Kendra Berger | By: /s/ Jeffrey A. Berg |
| Authorized Signature | Authorized Signature |
| Kendra Berger | Jeffrey A. Berg |
| Print Name | Print Name |
| CFO | President |
| Title | Title |
| January 11, 2013 | January 11, 2013 |
| Date | Date |